Myocardial recovery in patients with chronic heart failure: Is it real?

Journal of Cardiac Surgery

Volumn 25, Issue 4, 2010, Pages 472-477

  Birks, Emma J ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; LOSARTAN; MOLECULAR MARKER; SPIRONOLACTONE;

CONGESTIVE CARDIOMYOPATHY; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MYOCARDITIS; POSTOPERATIVE PERIOD; PROTEIN EXPRESSION; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME;

DISEASE PROGRESSION; FIBROSIS; GENE THERAPY; HEALTH STATUS INDICATORS; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; KIDNEY FAILURE, CHRONIC; MYOCARDIUM; QUALITY OF LIFE; STEM CELLS; TREATMENT OUTCOME;

EID: 77954361838     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2010.01051.x     Document Type: Review

References (33)

1. Frazier OH, Radovancevic B, Abou-Awdi NL, et al : Ventricular remodelling after prolonged ventricular unloading "Heart Rest" experience with the heartmate left ventricular assist device. J Heart Lung Transplant 1994 13 (1, pt 2 77.
2. Frazier OH, Benedict CR, Radovancevic B, et al : Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg 1996 62 : 675 682.
3. Levin HR, Oz MC, Chen JM, et al : Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation 1995 91 (11 2717 2720.
4. Levin HR, Oz MC, Cantanese KA, et al : Transient normalisation of systolic and diastolic function after support with a left ventricular assist device in a patient with dialed cardiomyopathy. J Heart Lung Transplant 1996 15 : 840 842.
5. Frazier OH, Myers TJ : Left ventricular assist system as a bridge to myocardial recovery. Ann Thorac Surg 1999 68 (2 734 741.
6. Mancini DM, Beniaminovitz A, Levin H, et al : Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 1998 98 : 2383 2389. (Pubitemid 28549781)
7. Farrar DJ, Holman WR, McBride LR, et al : Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant 2002 21 (5 516 521.
8. Simon MA, Kormos RL, Murali S, et al : Myocardial recovery using ventricular assist devices: Prevalence, clinical characteristics, and outcomes. Circulation 2005 112 (9 Suppl I32 I36.
9. Muller J, Wallukat G, Weng YG, et al : Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 1997 96 (2 542 549. (Pubitemid 27329431)
10. Loebe M, Hennig E, Muller J, et al : Long-term mechanical circulatory support as a bridge to transplantation, for recovery from cardiomyopathy, and for permanent replacement. Eur J Cardiothoracic Surg 1997 11 (Suppl S18 S24.
11. Dandel M, Weng Y, Siniawski H, et al : Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation 2005 112 (9 Suppl I37 I45.
12. Dandel M, Weng Y, Siniawski H, et al : Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy. Circulation 2008 118 (1 Suppl S94 S105.
13. Birks EJ, Tansley PD, Hardy J, et al : Left ventricular assist device and drug therapy for the reversal of heart failure. New Engl J Med 2006 355 (18 1873 1884.
14. Wong K, Boheler KR, Bishop J, et al : Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features. Cardiovasc Res 1998 37 : 115 122.
15. George RS, Yacoub MH, Tasca G, et al : Haemodynamic and echocardiographic responses to acute interruption of left ventricular assist device support - Relevance to assessment of myocardial recovery. J Heart Lung Transplant 2007 26 (10 967 973.
16. Haj-Yahia S, Birks EJ, Rogers P, et al : Midterm experience with the Jarvik 2000 axial flow left ventricular assist device. J Thorac Cardiovasc Surg 2007 134 (1 199 203.
17. Birks EJ, George RS, Hedger M, et al : Myocardial recovery from advanced heart failure using the HeartMate II LVAD combined with drug therapy: Early results from a prospective study. J Heart Lung Transplantation 2009 28 : 2S.
18. Komoda T, Komoda S, Dandel M, et al : Explantation of INCOR left ventricular assist device after myocardial recovery. J Card Surg 2008 Nov-Dec 23 (6 642 647.
19. George RS, Sabharwal NK, Webb C, et al : Echocardiographic evaluation of flow across HeartMate II axial flow LVADs at varying low speeds. J Heart Lung Transplantation 2009 28 : 2S.
20. Khan T, Delgado RM, Radovancevic B, et al : Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): Hemodynamic and histologic evidence of improvement before LVAD explantation. J Heart Lung Transplant 2003 22 (2 137 146.
21. Slaughter M, Silver M, Farrar D, et al : A new method of monitoring recovery and weaning the Thoratec LVAD. Ann Thorac Surg 2001 71 : 215 218.
22. Maybaum S, Mancini D, Xydas S, et al : Cardiac improvement during mechanical circulatory support a prospective multicentre study of the LVAD Working Group. Circulation 2007 115 : 2497 2505.
23. George RS, Yacoub MH, Bowles CT, et al : Quality of life after removal of left ventricular assist device for myocardial recovery. J Heart Lung Transplant 2008 27 (2 165 172.
24. Klotz S, Jan Danser AH, Burkhoff D : Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process. Prog Biophys Mol Biol 2008 97 : 479 496.
25. Wohlschlaeger J, Schmitz KJ, Schmid C, et al : Reverse remodeling following insertion of left ventricular assist devices (LVAD): A review of the morphological and molecular changes. Cardiovasc Res 2005 68 (3 376 386.
26. Birks EJ, Hall JL, Barton PJ, et al : Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support. Circulation 2005 112 (9 Suppl I57 I64.
27. Latif N, Yacoub MH, George R, et al : Changes in sarcomeric and non-sarcomeric cytoskeletal proteins and focal adhesion molecules during clinical myocardial recovery after left ventricular assist device support. J Heart Lung Transplant 2007 26 (3 230 235.
28. Cullen ME, Yuen AH, Felkin LE, et al : Myocardial expression of the Arginine:Glycine amidinotransferase gene is elevated in heart failure and normalized following recovery: Potential implications for local creatine synthesis. Circulation 2006 114 : 16 20.
29. Barton PJR, Felkin LE, Birks EJ, et al : Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy. Circulation 2005 112 (9 Suppl I46 I50.
30. Lara-Pezzi E, Felkin LE, Birks EJ, et al : Expression of follistatin-related genes is altered in heart failure. Endocrinology 2008 149 (11 5822 5827.
31. Felkin LE, Lara-Pezzi E, George R, et al : Expression of extracellular matrix genes during myocardial recovery from heart failure following left ventricular assist Device (LVAD) Support. J Heart Lung Transplantation 2009 28 (2 117 122.
32. Terracciano CMN, Hardy J, Birks EJ, et al : Clinical recovery from end-stage heart failure using Left Ventricular Assist Device and Pharmacologic Therapy correlates with increased sarcoplasmic reticulum calcium content, but not with regression of cellular hypertrophy. Circulation 2004 109 : 2263 2265.
33. Hall JL, Birks EJ, Grindle S, et al : Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. Eur Heart J 2007 28 (5 613 627.